Skip to content

Definium Therapeutics

US · DFTX #2132 by market cap Listed 1970
28.34 -1.14 -3.87%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Definium Therapeutics

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Founded
2010
CEO
Mr. Robert B. Barrow
Employees
106
Headquarters
New York, New York, United States of America
Fiscal year end
12-31
Website
definiumtx.com

Company profile

Exchange
US
Symbol
DFTX
Market-cap rank
#2132
Listing date
1970-01-01
Market cap
3.88B
Float cap
3.63B
Shares out
136.90M
Float shares
128.19M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:39 · For reference only, not investment advice and not tailored to your situation.

Definium Therapeutics discussion 0 comments

Add a comment